Construction of drug screening cell model and application to new compounds inhibiting FITC-fibrinogen binding to CHO cells expressing human alphaIIbbeta3.
Yang J, Yao J, Chen J, Wang XN, Zhu TY, Chen LL, Chu P.
Yang J, et al.
Eur J Pharmacol. 2009 Sep 15;618(1-3):1-8. doi: 10.1016/j.ejphar.2009.07.011. Epub 2009 Jul 17.
Eur J Pharmacol. 2009.
PMID: 19619528
To identify potential candidates for antiplatelet drugs, human alphaIIbbeta3 (GPIIb/IIIa) was expressed in Chinese hamster ovary (CHO) cells, which was validated by tetrapeptide RGDS (Arg-Gly-Asp-Ser) with IC(50) of 0.057 mM, supported by Basani's results [Basani, R. B., French, …
To identify potential candidates for antiplatelet drugs, human alphaIIbbeta3 (GPIIb/IIIa) was expressed in Chinese hamster ovary (CHO) cells …